Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
JAMA Neurology|December 6, 2021
Twenty-Year Change in Severity and Outcome of Ischemic and Hemorrhagic StrokesKazunori Toyoda, Sohei Yoshimura, Michikazu Nakai, et al.
Cerebrovascular Diseases (Basel, Switzerland)|July 24, 2020
Brain Imaging Signs and Health-Related Quality of Life after Acute Ischemic Stroke: Analysis of ENCHANTED Alteplase Dose ArmXiaoying Chen, Candice Delcourt, Lingli Sun, et al.
European Stroke Journal|January 3, 2025
Effects of sex on imaging-based intravenous thrombolysis for ischaemic stroke with unknown onset time: a pooled analysis of clinical trialsMayumi Fukuda-Doi, Masatoshi Koga, Götz Thomalla, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|February 8, 2025
Efficacy and safety of intravenous alteplase for unknown onset stroke on prior antiplatelet therapy: Post hoc analysis of the EOS individual participant dataYuma Shiomi, Kaori Miwa, Märit Jensen, et al.
European Journal of Neurology|October 17, 2020
Intensive versus guideline-recommended blood pressure reduction in acute lacunar stroke with intravenous thrombolysis therapy: The ENCHANTED trialZien Zhou, Chao Xia, Cheryl Carcel, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|February 27, 2026
Long-term Risk of Bleeding Events in Patients Taking Antithrombotic Agents for Cerebrovascular or Cardiovascular DiseaseSohei Yoshimura, Kaori Miwa, Masatoshi Koga, et al.
Cancers|November 13, 2021
Hepatic Arterial Infusion Chemotherapy with Cisplatin versus Sorafenib for Intrahepatic Advanced Hepatocellular Carcinoma: A Propensity Score-Matched AnalysisYuki Zaizen, Masahito Nakano, Kazuta Fukumori, et al.
Stroke|August 23, 2022
Alteplase for Stroke With Unknown Onset Time in Chronic Kidney Disease: A Pooled Analysis of Individual Participant DataKaori Miwa, Masatoshi Koga, Märit Jensen, et al.
Journal of Atherosclerosis and Thrombosis|February 24, 2022
Intravenous Alteplase at 0.6 mg/kg for Unknown Onset Stroke with Prior Antithrombotic Medication: THAWS Randomized Clinical TrialMasatoshi Koga, Manabu Inoue, Kaori Miwa, et al.
Stroke|December 10, 2020
Magnetic Resonance Imaging-Guided Thrombolysis (0.6 mg/kg) Was Beneficial for Unknown Onset Stroke Above a Certain Core Size: THAWS RCT SubstudyKazunori Toyoda, Manabu Inoue, Sohei Yoshimura, et al.
Pageof 11